financetom
Business
financetom
/
Business
/
Argan Fiscal Q2 Earnings, Revenue Rise; Shares Soar After Hours
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Argan Fiscal Q2 Earnings, Revenue Rise; Shares Soar After Hours
Sep 6, 2024 1:19 PM

04:51 PM EDT, 09/05/2024 (MT Newswires) -- Argan (AGX) reported fiscal Q2 earnings late Thursday of $1.31 per diluted share, up from $0.94 a year earlier.

Two analysts polled by Capital IQ expected EPS of $0.97.

Revenue for the quarter that ended July 31 was $227 million, up from $141.4 million a year earlier.

Two analysts surveyed by Capital IQ projected $191.1 million.

Shares of the company were up nearly 18% in after-hours activity.

Price: 83.96, Change: +12.58, Percent Change: +17.62

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Rupert Resources Q4 Loss Narrows on Cost Cuts and Decline in Impairments
Rupert Resources Q4 Loss Narrows on Cost Cuts and Decline in Impairments
May 29, 2024
08:31 AM EDT, 05/29/2024 (MT Newswires) -- Rupert Resources ( RUPRF ) , which rose 1.8% yesterday, said on Wednesday that its fourth-quarter loss narrowed amid a decrease in general and administrative costs, a decline in impairment of exploration and evaluation assets, and a decrease in share-based payments. The company reported a fourth-quarter total comprehensive loss attributable to owners of...
Heron Therapeutics Submits Prior Approval Supplement to the FDA for Zynrelef Vial Access Needle
Heron Therapeutics Submits Prior Approval Supplement to the FDA for Zynrelef Vial Access Needle
May 29, 2024
08:35 AM EDT, 05/29/2024 (MT Newswires) -- Heron Therapeutics ( HRTX ) said Wednesday it submitted the prior approval supplement to the US Food and Drug Administration for Zynrelef's extended-release solution Vial Access Needle. The company is seeking approval for the new Zynrelef kit, which could simplify preparation and reduce the drug's withdrawal time to 20 to 45 seconds from...
Streamline Health Solutions Enters Contract With 400-Bed Health System
Streamline Health Solutions Enters Contract With 400-Bed Health System
May 29, 2024
08:28 AM EDT, 05/29/2024 (MT Newswires) -- Streamline Health Solutions ( STRM ) said Wednesday that it has signed a new contract in partnership with Oracle (ORCL) for the use of its RevID automated charge reconciliation product at 400-bed, southern California health system. Financial details of the deal were not disclosed. ...
Dick's Sporting Goods Q1 Earnings: Revenue Growth, Net Store Closures And Hike In Profit Outlook
Dick's Sporting Goods Q1 Earnings: Revenue Growth, Net Store Closures And Hike In Profit Outlook
May 29, 2024
Dick's Sporting Goods Inc (NYSE:DKS) shares are trading higher after the company reported better-than-expected first-quarter FY24 earnings and raised the outlook. The company reported first-quarter FY24 sales growth of 6.2% year-on-year to $3.02 billion, beating the analyst consensus estimate of $2.94 billion. Comparable store sales increased 5.3% versus a 3.6% growth a year ago. Adjusted EPS of $3.30 beat the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved